Background Image
Table of Contents Table of Contents
Previous Page  221 / 274 Next Page
Information
Show Menu
Previous Page 221 / 274 Next Page
Page Background

Draft 6. Note: This document is a draft suggestion only and is not an approved document.

Please do not distribute to laboratory staff for use.

5.3.3

Frequently, it will be necessary to segregate certain types of work that are prone to interference from other

work, or which present particular problems or hazards. Examples include but are not limited to areas for reagent

preparation or trace analysis instrumentation where physical separation to avoid systems contamination is necessary.

When selecting designated areas for special work, account shall be taken of the previous use of the area. Before use,

confirm the area is ready for use. Once in use, access to such areas shall be restricted, as needed, and the type of work

undertaken there carefully controlled.

5.3.4

“It may be necessary to restrict access to particular areas of a laboratory because of the nature of the work

carried out there. Restrictions might be made because of security, safety, or sensitivity to contamination or

interferences. Typical examples might be work involving explosives, radioactive materials, sterility testing,

carcinogens, forensic examination, polymerase chain reaction (PCR) techniques, and trace analysis. Where such

restrictions are in force, staff shall be appropriately trained on the:

intended use of a particular area

restrictions imposed on working within such areas

reasons for imposing such restrictions

procedures to follow when such restrictions are breached"

[

CITAC/Eurachem Guide to Quality in Analytical Chemistry: An Aid to Accreditation

(2002)]

5.3.5

For pharmaceutical laboratories, cleaning and sanitization schedules shall be established by the laboratory for

laboratory areas (benches, floors, etc.) and for laboratory equipment (incubators, water baths, centrifuges,

refrigerators, freezers, etc.). Sanitization of key areas and equipment shall be recorded.

For microbiological testing, in cases where sterile supplies are necessary, the supplies shall be purchased as sterile or

sterilized in the laboratory (e.g., gloves, pipettes, pipette tips, petri dishes, tongs, etc.). If the laboratory sterilizes the

item, it shall maintain the item in a sterile condition/environment.

5.4 Test and Calibration Methods and Method Validation

5.4.2

Selection of Methods

Matrix and analyte matched Certified Reference Materials, when available, shall be used to determine any systematic

method bias. Where this is not possible, method bias shall be determined by using a variety of techniques, preferably

based on different principles of analysis. All laboratory-developed and non-standard methods shall be fully

documented, including validation data, limitations of applicability, procedures for quality control, and calibration.

Determination of measurement uncertainty shall form part of the method validation process.

The laboratory must confirm it can properly perform standard methods

before

these are used in routine testing (e.g. it

is not appropriate for the laboratory to run concurrent controls and/or reference materials in order to qualify their

competence to perform the method at same time they are running the sample, rather the laboratory must be able to

properly prove the method is fit for purpose beforehand).

Note

: Where no method is specified, the laboratory shall choose an appropriate method. Examples of food, dietary

supplement, and pharmaceutical methods are found in AOAC, USDA, FDA, EPA, AOCS, AACC, ISO, IUPAC, USP,

and FCC method manuals. Many trade associations publish their own methods and provide useful resources. A few

examples include the Corn Refiners Association, National Food Processors Association, Association for Dressings

and Sauces, and the American Spice Trade Association.

The laboratory shall record the laboratory representative who authorized adoption of the method and the date this

authorization was granted.

Adjustments to maintain system suitability specifications that do not alter the fundamental nature of the method may

be made without validation. Modifications of methods that alter the fundamental nature of the method shall be

validated to demonstrate that equivalent results are obtained and that the method is suitable for its intended use.

165